RMD logo

RMD
Resmed Inc.

2,068
Mkt Cap
$29.99B
Volume
878,611.00
52W High
$293.81
52W Low
$198.64
PE Ratio
19.93
RMD Fundamentals
Price
$199.72
Prev Close
$206.76
Open
$205.16
50D MA
$228.11
Beta
0.77
Avg. Volume
1.06M
EPS (Annual)
$9.51
P/B
4.62
Rev/Employee
$485,502.55
$37,643.00
Loading...
Loading...
News
all
press releases
Here's Why ResMed (RMD) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Birch Capital Management LLC Reduces Stock Holdings in ResMed Inc. $RMD
Birch Capital Management LLC reduced its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 24.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 26,899 shares of the medical equipment provider's stock after selling 8,642 shares du...
MarketBeat·6d ago
News Placeholder
PFA Pension Forsikringsaktieselskab Buys Shares of 188,393 ResMed Inc. $RMD
PFA Pension Forsikringsaktieselskab bought a new stake in ResMed Inc. (NYSE:RMD - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities...
MarketBeat·8d ago
News Placeholder
ResMed Q3 Earnings Call Highlights
ResMed (NYSE:RMD) reported third-quarter fiscal 2026 results highlighted by revenue growth, gross margin expansion, and higher non-GAAP earnings per share, while also announcing a CFO transition and a planned tuck-in acquisition to expand beyond its core sleep apnea business. Leadership updates: CF...
MarketBeat·9d ago
News Placeholder
Royal Bank Of Canada Forecasts Strong Price Appreciation for ResMed (NYSE:RMD) Stock
Royal Bank Of Canada lifted their price target on ResMed from $314.00 to $321.00 and gave the company an "outperform" rating in a research report on Friday...
MarketBeat·10d ago
News Placeholder
ResMed (NYSE:RMD) Shares Down 6% on Analyst Downgrade
ResMed (NYSE:RMD) Shares Down 6% Following Analyst Downgrade...
MarketBeat·10d ago
News Placeholder
Wells Fargo & Company Issues Pessimistic Forecast for ResMed (NYSE:RMD) Stock Price
Wells Fargo & Company lowered their price target on shares of ResMed from $270.00 to $227.00 and set an "equal weight" rating on the stock in a report on Friday...
MarketBeat·10d ago
News Placeholder
ResMed Inc. (NYSE:RMD) Plans Quarterly Dividend of $0.60
ResMed Inc. (NYSE:RMD) announced a quarterly dividend on Thursday, April 30th. Stockholders of record on Thursday, May 14th will be paid a dividend of 0.60 per share by the medical equipment provider...
MarketBeat·10d ago
News Placeholder
RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins Rise
Resmed beats Q3 earnings and revenue estimates with strong margin gains, yet shares slip post earnings despite growth across key segments.
Zacks·10d ago
News Placeholder
Transcript: ResMed Q3 2026 Earnings Conference Call
read more...
Benzinga·11d ago
<
1
2
...
>

Latest RMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.